Drreddys Laboratories | RDY - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
ANI Pharmaceuticals USD 91.66M 18.01M 2026-06
Aurora Cannabis CAD 40.89M 515K 2026-06
Bayer EUR 3.96B 267M 2026-06
Canopy Growth CAD 33.99M 2.83M 2026-06
Cipla INR 13.25B 101.8M 2025-12
Corcept Therapeutics USD 156.9M 28.85M 2026-06
Drreddys Laboratories INR 28.08B 13.61B 2026-09
GlaxoSmithKline GBP 2.16B 39M 2026-09
Hikma Pharmaceutical USD 288M 149M 2025-12
Novartis USD 3.08B 163M 2026-09
Pacira USD 91.81M 7.93M 2026-06
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 43.3M 13.02M 2026-06
Richter Gedeon HUF 57.76B 2.43B 2026-06
Sun Pharmaceuticals INR 24.89B 637.6M 2025-03
Supernus Pharmaceuticals USD 133.64M 15.41M 2026-06
Teva Pharmaceutical Industries USD 1.03B 34M 2026-06